Experiments conducted by Chen et al. showed that inhibition of anti-tumor response might not only occur through the interaction of tumor receptors with T cell-expressed CTLA-4, but also via suppression of dendritic cell function as a consequence of their interaction with CTLA-4+ breast cancer cells. Here, CTLA4 is linked to breast carcinoma.